Ezzat Elhassadi, MD

Articles by Ezzat Elhassadi, MD

Dr. Elhassadi on the Subtypes of MCL

July 10th 2019

Ezzat Elhassadi, MD, consultant hematologist, Hematology Services, University Hospital Waterford, discusses the subtypes of mantle cell lymphoma (MCL).

Dr. Elhassadi on the Relationship Between p53 Expression and Prognosis in MCL

ByEzzat Elhassadi, MD

June 27th 2019

Ezzat Elhassadi, MD, consultant hematologist, Hematology Services, University Hospital Waterford, discusses p53 expression and prognosis in mantle cell lymphoma (MCL).

Dr. Elhassadi on 10-Year Single-Center Experience With TP53 Status in MCL

ByEzzat Elhassadi, MD

June 21st 2019

Ezzat Elhassadi, MD, consultant hematologist, Hematology Services, University Hospital Waterford, discusses a 10-year single-center experience with TP53 status in mantle cell lymphoma (MCL).

Dr. Elhassadi Discusses the Outlook of Patients With p53-Mutated MCL

ByEzzat Elhassadi, MD

June 19th 2019

Ezzat Elhassadi, MD, consultant hematologist, Haematology Services, University Hospital Waterford, discusses the outlook of patients with p53-mutated mantle cell lymphoma.